INTERNATIONAL PATENT: VAXCELL-BIO CO., LTD., 주식회사 박셀바이오, KONGJU NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION, 국립공주대학교 산학협력단 FILES APPLICATION FOR "ANTIBODY TARGETING CANINE CD20, CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF"

Posted On: 2025-06-18

GENEVA, June 18 -- VAXCELL-BIO CO., LTD. (1F, 12-55 Sandan-gil, Hwasun-eupHwasun-gunJeollanam-do 58141), 주식회사 박셀바이오 (전라남도화순군화순읍 산단길 12-55, 1층), KONGJU NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (56 Gongjudaehak-roGongju-siChungcheongnam-do 32588), 국립공주대학교 산학협력단 (충청남도공주시공주대학로 56) filed a patent application (PCT/KR2024/019944) for "ANTIBODY TARGETING CANINE CD20, CHIMERIC ANTIGEN RECEPTOR, AND USE TH...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: VAXCELL-BIO CO., LTD., 주식회사 박셀바이오, KONGJU NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION, 국립공주대학교 산학협력단 FILES APPLICATION FOR "ANTIBODY TARGETING CANINE CD20, CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF"